Generate Investment Management Ltd Purchases Shares of 30,922 Stryker Corporation $SYK

Generate Investment Management Ltd acquired a new position in shares of Stryker Corporation (NYSE:SYK) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 30,922 shares of the medical technology company’s stock, valued at approximately $10,868,000.

Several other large investors have also modified their holdings of SYK. Clayton Financial Group LLC purchased a new position in shares of Stryker in the 3rd quarter valued at $26,000. United Financial Planning Group LLC purchased a new stake in Stryker in the third quarter valued at $27,000. Elevation Point Wealth Partners LLC acquired a new position in Stryker in the second quarter valued at $28,000. Kilter Group LLC acquired a new position in Stryker in the second quarter valued at $29,000. Finally, Howard Hughes Medical Institute purchased a new position in shares of Stryker during the second quarter worth about $29,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Stryker Price Performance

Shares of NYSE:SYK opened at $327.49 on Friday. Stryker Corporation has a one year low of $324.93 and a one year high of $404.87. The stock has a market capitalization of $125.42 billion, a price-to-earnings ratio of 38.99, a PEG ratio of 1.94 and a beta of 0.85. The company has a 50-day simple moving average of $360.17 and a 200-day simple moving average of $363.90. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.21 and a current ratio of 1.89.

Stryker (NYSE:SYK) last released its quarterly earnings results on Thursday, January 29th. The medical technology company reported $4.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.40 by $0.07. The firm had revenue of $7.17 billion for the quarter, compared to analyst estimates of $7.12 billion. Stryker had a return on equity of 24.41% and a net margin of 12.92%.The business’s revenue was up 11.4% on a year-over-year basis. During the same quarter last year, the company posted $4.01 earnings per share. On average, analysts predict that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, April 30th. Stockholders of record on Tuesday, March 31st will be issued a $0.88 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.1%. Stryker’s payout ratio is presently 41.90%.

Analyst Ratings Changes

A number of research firms have recently commented on SYK. Sanford C. Bernstein lifted their target price on Stryker from $450.00 to $465.00 and gave the stock an “outperform” rating in a research report on Friday, January 9th. Robert W. Baird set a $437.00 price target on Stryker in a research note on Friday, January 30th. Raymond James Financial raised Stryker from a “market perform” rating to an “outperform” rating and set a $418.00 price target on the stock in a research report on Tuesday, January 6th. William Blair reiterated an “outperform” rating on shares of Stryker in a research note on Thursday, March 5th. Finally, Jefferies Financial Group reissued a “buy” rating and issued a $465.00 price objective on shares of Stryker in a report on Wednesday, March 4th. Fourteen research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $427.50.

Insider Activity

In other news, Director Ronda E. Stryker sold 250,000 shares of the company’s stock in a transaction that occurred on Wednesday, February 4th. The stock was sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the completion of the sale, the director owned 2,457,331 shares in the company, valued at $891,814,566.52. This represents a 9.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 5.90% of the company’s stock.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.